Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
192.2 USD | -1.53% | -4.66% | -25.74% |
03:58pm | UBS Adjusts Biogen's Price Target to $214 From $250, Maintains Neutral Rating | MT |
01:26pm | Wedbush Cuts Biogen's Price Target to $213 From $245 | MT |
Financials (USD)
Sales 2024 * | 9.46B | Sales 2025 * | 9.58B | Capitalization | 28.37B |
---|---|---|---|---|---|
Net income 2024 * | 1.89B | Net income 2025 * | 2.26B | EV / Sales 2024 * | 3.28 x |
Net Debt 2024 * | 2.69B | Net Debt 2025 * | 288M | EV / Sales 2025 * | 2.99 x |
P/E ratio 2024 * |
14.8
x | P/E ratio 2025 * |
12.6
x | Employees | 7,570 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.34% |
Latest transcript on Biogen Inc.
1 day | -0.54% | ||
1 week | -4.66% | ||
Current month | -10.88% | ||
1 month | -12.42% | ||
3 months | -21.65% | ||
6 months | -28.15% | ||
Current year | -25.74% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 64 | 22-11-13 | |
Director of Finance/CFO | 60 | 20-08-14 | |
Nicole Murphy
COO | Chief Operating Officer | - | 14-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Sherwin
BRD | Director/Board Member | 75 | 09-12-31 |
William Hawkins
BRD | Director/Board Member | 70 | 19-06-18 |
Caroline Dorsa
CHM | Chairman | 64 | 10-01-02 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
4.30% | 1 M€ | -1.52% | - | |
3.92% | 0 M€ | 0.00% | - | |
3.75% | 0 M€ | 0.00% | - | |
2.39% | 14,021 M€ | +2.78% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-17 | 192.2 | -1.53% | 1 320 595 |
24-04-16 | 195.2 | -0.84% | 872,004 |
24-04-15 | 196.8 | -0.70% | 1,159,247 |
24-04-12 | 198.2 | -2.70% | 1,245,896 |
24-04-11 | 203.7 | +1.06% | 1,019,056 |
Delayed Quote Nasdaq, April 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.74% | 28.37B | |
-4.89% | 85.08B | |
+2.11% | 40.14B | |
+51.96% | 24.07B | |
-6.17% | 17.24B | |
-31.09% | 13.85B | |
-6.58% | 12.29B | |
-16.04% | 11.95B | |
-4.19% | 8.02B | |
+7.08% | 7.73B |
- Stock Market
- Equities
- BIIB Stock